- Home
- GRDN vs ADAMZ Comparison
GRDN vs ADAMZ Comparison
Compare GRDN & ADAMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- ADAMZ
- Stock Information
- Founded
- GRDN 2004
- ADAMZ N/A
- Country
- GRDN United States
- ADAMZ United States
- Employees
- GRDN N/A
- ADAMZ N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- ADAMZ Real Estate Investment Trusts
- Sector
- GRDN Consumer Staples
- ADAMZ Real Estate
- Exchange
- GRDN Nasdaq
- ADAMZ Nasdaq
- Market Cap
- GRDN 1.7B
- ADAMZ 1.6B
- IPO Year
- GRDN 2024
- ADAMZ N/A
- Fundamental
- Price
- GRDN $31.52
- ADAMZ $18.80
- Analyst Decision
- GRDN Strong Buy
- ADAMZ
- Analyst Count
- GRDN 2
- ADAMZ 0
- Target Price
- GRDN $30.00
- ADAMZ N/A
- AVG Volume (30 Days)
- GRDN 345.1K
- ADAMZ N/A
- Earning Date
- GRDN 11-10-2025
- ADAMZ N/A
- Dividend Yield
- GRDN N/A
- ADAMZ N/A
- EPS Growth
- GRDN N/A
- ADAMZ N/A
- EPS
- GRDN 0.64
- ADAMZ N/A
- Revenue
- GRDN $1,389,638,000.00
- ADAMZ N/A
- Revenue This Year
- GRDN $16.33
- ADAMZ N/A
- Revenue Next Year
- GRDN $2.10
- ADAMZ N/A
- P/E Ratio
- GRDN $49.27
- ADAMZ N/A
- Revenue Growth
- GRDN 18.68
- ADAMZ N/A
- 52 Week Low
- GRDN $17.78
- ADAMZ N/A
- 52 Week High
- GRDN $37.43
- ADAMZ N/A
- Technical
- Relative Strength Index (RSI)
- GRDN 75.47
- ADAMZ N/A
- Support Level
- GRDN $27.39
- ADAMZ N/A
- Resistance Level
- GRDN $37.43
- ADAMZ N/A
- Average True Range (ATR)
- GRDN 1.63
- ADAMZ 0.00
- MACD
- GRDN 0.27
- ADAMZ 0.00
- Stochastic Oscillator
- GRDN 42.21
- ADAMZ 0.00
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.